16714-117 : Rivastigmine 13.3 mg/24h Transdermal Patch, Extended Release


NDC: 16714-117
Labeler: Northstar Rx LLC.
Product Type: Human Prescription Drug
Drug Name:  Rivastigmine
Dosage Form: Transdermal Patch, Extended Release
Application #: ANDA206318
Rev. Date: 


NDC Package Codes:

  • 16714-117-02: 30 POUCH IN 1 CARTON (16714‑117‑02) > 24 H IN 1 POUCH (16714‑117‑01)

Active Ingredients:

  • Rivastigmine

Dosage Strength:

  • 13.3 mg/24h

Pharmaceutical Classes:

  • Cholinesterase Inhibitor [EPC]
  • Cholinesterase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 16714-115 Rivastigmine 4.6 mg/24h Transdermal Patch, Extended Release by Northstar Rx LLC.
  • 16714-116 Rivastigmine 9.5 mg/24h Transdermal Patch, Extended Release by Northstar Rx LLC.
  • 0378-9070 Rivastigmine 4.6 mg/24h Transdermal Patch by Mylan Pharmaceuticals Inc.
  • 0378-9071 Rivastigmine 9.5 mg/24h Transdermal Patch by Mylan Pharmaceuticals Inc.
  • 0378-9072 Rivastigmine 13.3 mg/24h Transdermal Patch by Mylan Pharmaceuticals Inc.
  • 0781-7304 Rivastigmine 4.6 mg/24h Transdermal Patch, Extended Release by Sandoz Inc
  • 0781-7309 Rivastigmine 9.5 mg/24h Transdermal Patch, Extended Release by Sandoz Inc
  • 0781-7313 Rivastigmine 13.3 mg/24h Transdermal Patch, Extended Release by Sandoz Inc
  • 51956-0001 Rivastigmine 4.6 mg/24h Transdermal Patch, Extended Release by Zydus Technologies Limited
  • 51956-0002 Rivastigmine 9.5 mg/24h Transdermal Patch, Extended Release by Zydus Technologies Limited
  • 51956-0003 Rivastigmine 13.3 mg/24h Transdermal Patch, Extended Release by Zydus Technologies Limited
  • 65162-749 Rivastigmine 13.3 mg/24h Transdermal Patch by Amneal Pharmaceuticals LLC
  • 65162-825 Rivastigmine 4.6 mg/24h Transdermal Patch by Amneal Pharmaceuticals LLC
  • 65162-826 Rivastigmine 9.5 mg/24h Transdermal Patch by Amneal Pharmaceuticals LLC
  • 70710-1196 Rivastigmine 4.6 mg/24h Transdermal Patch, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
  • 70710-1197 Rivastigmine 9.5 mg/24h Transdermal Patch, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
  • 70710-1198 Rivastigmine 13.3 mg/24h Transdermal Patch, Extended Release by Zydus Pharmaceuticals (Usa) Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 16714-117 QR Code

< Prev: 16714-116Next: 16714-118 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.